Epigenetics
-
XL019
Catalog No. A12394 -
PF-03394197 (oclacitinib)
Catalog No. A13082 -
Pyridone 6 (JAK Inhibitor I)
Catalog No. A13457 -
PRT 062070 (Cerdulatinib)
Catalog No. A14147 Dual Syk and JAK 抑制剂PRT 062070 (Cerdulatinib)是一种新型的口服双脾酪氨酸激酶(Syk)和janus激酶(JAK)抑制剂。Cerdulatinib优先抑制各种细胞类型中JAK1和JAK3依赖性细胞因子介导的信号传导和功能性反应。 了解更多 -
NSC 42834(JAK2 Inhibitor V, Z3)
Catalog No. A14132 -
Cerdulatinib
Catalog No. A14210 multi-targeted tyrosine kinase 抑制剂Cerdulatinib (PRT-062070)是多靶点酪氨酸激酶抑制剂,对JAK1/JAK2/JAK3/TYK2和Syk的IC50分别为12 nM/6 nM/8 nM/0.5 nM和32 nM。 了解更多 -
Filgotinib
Catalog No. A14232 JAK 抑制剂Filgotinib是一种选择性的JAK1抑制剂,对于JAK1,JAK2,JAK3和TYK2的IC50分别为10 nM,28 nM,810 nM和116 nM。 了解更多 -
INCB39110 (Itacitinib)
Catalog No. A14390 JAK1 抑制剂INCB39110 (Itacitinib)是一种有效的JAK1酪氨酸激酶抑制剂,目前正在II期试验中,用于治疗类风湿关节炎,骨髓纤维化,类风湿关节炎和斑块状牛皮癣。 了解更多 -
Solcitinib (GSK2586184)
Catalog No. A14405 -
Decernotinib
Catalog No. A14012 -
ZM 39923 HCl
Catalog No. A13509 JAK3 抑制剂ZM 39923 HCl是JAK3抑制剂(IC50 = 79 nM),其抑制表皮生长因子受体,JAK1和细胞周期蛋白依赖性激酶4(IC50s分别为2.4、40和10 M)的抑制作用较小。 了解更多 -
S-Ruxolitinib
Catalog No. A14955 -
CYT387 sulfate salt
Catalog No. A15056 -
1,2,3,4,5,6-Hexabromocyclohexane
Catalog No. A15361 -
Cercosporamide
Catalog No. A15362 Mnk2/JAK3 抑制剂Cercosporamide是一种USnic酰胺,最初在Cercosporidium henningsii中被鉴定为宿主选择性植物毒素和广谱抗真菌剂,并且是MAP激酶相互作用激酶2(Mnk2;IC50 = 11 nM),JAK3(IC50 = 31)和Mnk1(IC50 = 116 nM)。 了解更多 -
Cucurbitacin I
Catalog No. A15363 JAK2/STAT3 抑制剂Cucurbitacin I(Cucumis sativus L.)可以抑制v-Src转化的NIH 3T3细胞中的磷酸酪氨酸Stat3(信号转导和转录激活因子3)水平。 了解更多 -
ZM 449829
Catalog No. A15366 -
Baricitinib phosphate
Catalog No. A15014 JAK 抑制剂Baricitinib phosphate是一种选择性的JAK1和JAK2抑制剂,IC50为5.9 nM和5.7 nM,选择性是JAK3和Tyk2的?70和?10倍,对c-Met和Chk2没有抑制作用。 了解更多 -
Peficitinib (ASP015K, JNJ-54781532)
Catalog No. A14438 -
NS-018
Catalog No. A16224 -
NS-018 hydrochloride
Catalog No. A16225 -
NS-018 maleate
Catalog No. A16226 JAK2 抑制剂NS-018 maleate是在Ba/F3-JAK2V617F细胞中具有ATP竞争性的JAK2小分子抑制剂,IC50为470nM。与其他JAK家族激酶(例如JAK1,JAK3和酪氨酸激酶2)相比,对JAK2的选择性高30-50倍。 了解更多 -
ZM39923
Catalog No. A16227 -
Gusacitinib
Catalog No. A19883 SYK/JAK inhibitorGusacitinib (ASN-002) is a potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 values of 5-46 nM. 了解更多 -
TG-02 (SB1317)
Catalog No. A11962 -
CHZ868
Catalog No. A15937 -
SB1317 (TG02)
Catalog No. A13454 CDK/JAK2/FLT3 抑制剂SB1317是细胞周期蛋白依赖性激酶(CDKs)、类FMS酪氨酸激酶-3(FLT3)和Janus激酶2(JAK2)的有效抑制剂,CDK2、JAK2和FLT3的IC50值分别为13nM、56nM和73nM。 了解更多 -
PF-06651600
Catalog No. A16803 JAK3 抑制剂PF-06651600是一种有效且不可逆的JAK3选择性抑制剂,IC50为33.1 nM,但对JAK1,JAK2和TYK2没有活性(IC50> 10 000 nM)。 了解更多 -
Ruxolitinib Phosphate
Catalog No. A11552 JAK 抑制剂Ruxolitinib Phosphate是ruxolitinib的磷酸盐形式,ruxolitinib是一种口服生物可利用的Janus相关激酶(JAK)抑制剂,具有潜在的抗肿瘤和免疫调节活性。 了解更多 -
PF-06700841 tosylate
Catalog No. A17176 -
JAK3-IN-2
Catalog No. A18323 JAK3 抑制剂JAK3-IN-2 is a potent and highly selective JAK3 inhibitor with IC50 of 0.15 nM. dispalys >4,300-fold selectivity over JAK1, JAK2 and TYK2, and other kinases BMX, EGFR, ITK and BTK; blocks cytokine signaling through JAK3, but not through other JAK family enzymes; inhibits IL-7 induced pSTAT5 in CD3+, CD8+ T cells with IC50 of 280 nM; sufficiently blocks the development of inflammation in a rat model of rheumatoid arthritis, while sparing hematopoiesis. 了解更多 -
Abrocitinib (PF-04965842)
Catalog No. A18318 JAK1 抑制剂Abrocitinib (PF-04965842) is a potent, orally active and selective JAK1 inhibitor, with IC50s of 29 and 803 nM for JAK1 and JAK2, respectively. Abrocitinib (PF-04965842) exhibits less active effect on TYK2 (IC50, 1.253 μM), and inhibits phosphorylation of STAT1, STAT3 and STAT5 after stimulation. Effective in autoimmune disease. 了解更多 -
Upadacitinib (ABT-494)
Catalog No. A18316 JAK-1 抑制剂Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor being developed for the treatment of several autoimmune disorders with an IC50 of 43 nM. IC50 & Target: IC50: 43 nM (JAK1), 200 nM (JAK2) 了解更多 -
BMS-986165
Catalog No. A18726 TYK2 抑制剂BMS-986165 is a Highly Potent and Selective Allosteric Inhibitor of TYK2. BMS-986165 Blocks Il-12, IL-23 and type I Interferon Signaling and Provides for Robust Efficacy in Preclinical Models of Inflammatory Bowel Disease. 了解更多 -
JAK3 covalent inhibitor-1
Catalog No. A18926 JAK3 covalent 抑制剂JAK3 covalent inhibitor-1 is a potent and selective janus kinase 3 (JAK3) covalent inhibitor with an IC50 of 11 nM and shows 246-fold selectivity vs other JAKs. 了解更多 -
Tofacitinib
Catalog No. A17252 JAK3/2/1 inhibitorTofacitinib is an orally available JAK3/2/1 inhibitor with IC50s of 1, 20, and 112 nM, respectively. 了解更多 -
PF-06263276
Catalog No. A12572 pan-JAK inhibitorPF-06263276 (PF 6263276) is a potent and selective pan-JAK inhibitor, with IC50s of 2.2 nM, 23.1 nM, 59.9 nM and 29.7 nM for JAK1, JAK2, JAK3 and TYK2, respectively. 了解更多